|Project name: ||Electronic Prescription Service (EPS) Release 2 - there are 5 reports for this project: 2013, 2014, 2015, 2016, 2017 |
|Google search: ||Google search on project name (opens in new window) |
|Organisation: ||DOH (D12) - see all reports for this organisation |
|Report year: ||2015 (data is from Sept 2014) |
|Category: ||ICT - see all reports for this category |
|Description: ||The Electronic Transmission of Prescriptions Programme is delivering the Electronic Prescription Service which is a national service that has its origins in government policy initiatives from 1998.
With 1.7 million prescriptions generated every working day in England and a predicted annual rise of 5 per cent, the Electronic Prescription Service provides an alternative means of generating and processing the growing number of prescriptions. The NHS Electronic Prescription Service enables prescribers, such as GPs and practice nurses, to send prescriptions electronically to a dispenser (such as a community pharmacy or dispensing appliance contractor) of the patients choice. Dispensing contractors can subsequently send electronic reimbursement endorsement claims to the NHS Prescription Service.
The main aims of the Electronic Transmission of Prescriptions programme are:
o To enable the electronic transmission of prescription data in England between:
- Prescribers (GP, nurses, supplementary);
- Dispensing contractors (community pharmacy, dispensing doctors and dispensing appliance contractors); and
- Reimbursement Agencies (e.g. the Business Services Authoritys NHS Prescription Services).
o To facilitate the efficient, convenient and accurate dispensing of medication to patients. The scope of the programme covers all primary care prescribing and dispensing (excluding Schedule 2 and 3 controlled drugs) and supply of medicines, drugs, appliances and chemical reagents by authorised dispensing contractors. Secondary care prescriptions issued for dispensing in the community are also within scope
o To enable the NHS Prescription Service to re-engineer their processes to increase capacity and reduce the unit cost of processing prescriptions.
The Electronic Prescription Service has to date delivered Release 2 Phase 3, which allows patients to nominate a pharmacy of their choice, at which to receive their prescription electronically. The move to Phase 4 will allow a patient to take their prescription token to any pharmacy for dispensing (as they do with their paper prescription today) with the ability to nominate a specific pharmacy continuing for those patients who prefer the service. |
|DCA (RAG): ||Amber |
|DCA text: ||The MPA RAG rating was Amber at Q2 2014.
The rated delivery confidence is Amber in view of the Programme needing to:
Focus on strategic risks and issues;
Restrict its Board membership;
Establish a Service Manager for the end to end patient experience;
Undertake a risk assessment;
Delineates deployment from business as usual;
Ensure an effective contract management process;
Resolve the controlled drugs and nomination issue; and
Appoint a Business Change manager.
The move to Phase 4 has been delayed from April 2015 to allow time to undertake a number of key activities to improve delivery confidence. These are to ensure robust business continuity arrangements are in place, implement a more formal arrangement with dispensing system suppliers, a full review of the service model, more robust patient communications, implementation of schedule 2 & 3 controlled drugs, and consideration of providing refresher training to dispensers. A review of the Programme Board structure and other governance arrangements will also be completed.
The most significant risk remains the outcome of the Home Office / Department of Health's three month public consultation to determine whether Schedule 2 & 3 Controlled Drugs should be brought into scope. The outcome could lead to a requirement for further technical changes.
The programme will exceed 2014/15 business case target for GP roll out with a forecasted 51% of GP sites live by the end of the year (the Business Case target was 43%). Utilisation, based on total sites deployed, is forecasted to end the year at 40% (the Business Case target was 42%). Almost 97% of pharmacies have been deployed (the Business Case target was 96%) and the team continue to work with all eligible pharmacies to increase take up. 66% of Dispensing Appliance Contractors have been deployed (the Business Case target was 99%) with 88% expected to go live by the end of 2014/15.
Further progress has been made in a number of important areas including dispensing system supplier contracts, filling vacancies in the Programme team and refresher training for pharmacy staff. |
|Start date: ||2003-01-01 |
|End date: ||2016-12-31 |
|Schedule text: ||Planning is underway to determine whether Phase 4 can be implemented by April 2016. |
|Baseline: ||£4.28m |
|Forecast: ||£4.55m |
|Variance: ||6.20% |
|Variance text: ||The revenue costs for 2014/15 are ahead of forecast, partly due to the higher than predicted take up of the Electronic Prescription Service Release 2 by GP practices in year and partly due to an anticipated increased spend on central staff. |
|Whole Life Cost: ||£77.74m |
|WLCost text: ||The Electronic Prescription Service Release 2 expenditure was approved in two separate business cases. The business case budget to the end of 2013/14 included costs for NHS Business Service Authority redundancies, Department of Health payments to pharmacies for adopting Electronic Prescription Service Release 2, NHS Primary Care Trust costs for GP practice training and NHS Connecting for Health / Health and Social Care Information Centre costs for staff and supplier Change Control Notices. The business case budget for the period from 14/15 onwards includes Clinical Commissioning Group costs for GP practice training and Health and Social Care Information Centre costs for staff and Spine Change Control Notices.
The rollout of Electronic Prescription Services Release 2 to prescribing sites has been slower than anticipated and the NHS Business Service Authority redundancies were not realised, hence the significant shortfall in costs expended and benefits realised to date. |
|Notes1: || DOH NON CAPITAL |
|Notes2: || |
|Sourcefile: ||IPA_2015.csv |
All Projects (+dates)
All Projects (+costs)
Acknowledgement: GMPP data has been re-used under the Open Government Licence.